298 related articles for article (PubMed ID: 1153500)
1. The effect of fenfluramine on disposition and rate of antipyrine elimination.
O'Malley K; Stevenson IH; West M
Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
[TBL] [Abstract][Full Text] [Related]
2. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
3. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
Breimer DD; Zilly W; Richter E
Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
[TBL] [Abstract][Full Text] [Related]
4. Effects of urea on hexobarbital and antipyrine disposition in rats.
Valentovic M; Bachmann K
Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
[TBL] [Abstract][Full Text] [Related]
5. Interaction between antipyrine and aminopyrine.
Vesell ES; Passananti GT; Hepner GW
Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
[TBL] [Abstract][Full Text] [Related]
6. Effect of the immunomodulator tilorone on antipyrine disposition in the rat.
Svensson CK
J Pharm Sci; 1986 Oct; 75(10):946-8. PubMed ID: 3795024
[TBL] [Abstract][Full Text] [Related]
7. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
[TBL] [Abstract][Full Text] [Related]
8. Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine.
Vesell ES; Passananti T; Glenwright PA
Pharmacology; 1975; 13(6):481-91. PubMed ID: 1221431
[TBL] [Abstract][Full Text] [Related]
9. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
Elin RJ; Vesell ES; Wolff SM
Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-fenfluramine on rat liver drug-metabolizing enzymes.
Conti I; Tridico RV; Duan L; Caccia S
Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):163-74. PubMed ID: 2047564
[TBL] [Abstract][Full Text] [Related]
12. Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.
Teunissen MW; Bakker W; Meerburg-Van der Torren JE; Breimer DD
Br J Clin Pharmacol; 1984 Nov; 18(5):701-6. PubMed ID: 6508979
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
Harman AE; Priestly BG; Frewin DB
Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
[TBL] [Abstract][Full Text] [Related]
14. Quinine-induced alterations in drug disposition.
Berlin CM; Stackman JM; Vesell ES
Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
[TBL] [Abstract][Full Text] [Related]
15. Altered elimination of antipyrine in patients with acute viral hepatitis.
Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
[TBL] [Abstract][Full Text] [Related]
16. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics of antipyrine in the rat.
Pollack GM; Li RC; Shen DD
Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
[TBL] [Abstract][Full Text] [Related]
18. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
Caraco Y; Zylber-Katz E; Berry EM; Levy M
Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
[TBL] [Abstract][Full Text] [Related]
19. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
20. Monthly variations in the clearance of antipyrine in the rat.
Bélanger PM; Doré F; Labrecque G
Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
